Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-008860)

Filing Details

Accession Number:: 0001209191-22-008860
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-11 16:22:08
Reporting Period:: 2022-02-09

Accepted Time:: 2022-02-11 16:22:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1557746	Aclaris Therapeutics Inc.	ACRS	Pharmaceutical Preparations (2834)	460571712

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1861790	Joseph Monahan	C/O Aclaris Therapeutics, Inc. 640 Lee Road, Suite 200 Wayne PA 19087	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-02-09	383	$12.68	87,301	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	193	Indirect	By Spouse

Footnotes

Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on February 1, 2022 pursuant to preexisting sell-to-cover elections.